Greater FDA Transparency Could Benefit Industry, Too, Trade Reps Say

Despite concerns with maintaining trade secret protections, industry has much to gain from increased openness by FDA, device industry representatives said at a June 24 meeting of FDA's new Transparency Task Force

More from Archive

More from Medtech Insight